{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:12:16Z","timestamp":1771272736480,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015758","name":"Novo Nordisk Pharma Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ando.2025.101722","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:03:25Z","timestamp":1741320205000},"page":"101722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pituitary dysfunction after cranial radiotherapy for brain tumor"],"prefix":"10.1016","volume":"86","author":[{"given":"Julie","family":"Chapon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Berthillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Klich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Tanguy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Perreton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Brac-de-la-Perri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Simonet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Lasolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2025.101722_bib0005","doi-asserted-by":"crossref","first-page":"R269","DOI":"10.1530\/EJE-16-1065","article-title":"Diagnosis of endocrine disease: expanding the cause of hypopituitarism","volume":"176","author":"Pekic","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101722_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ncpendmet1051","article-title":"Radiation-induced hypopituitarism after cancer therapy: who, how and when to test","volume":"5","author":"Darzy","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101722_bib0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000327584","article-title":"Endocrine outcome in long-term survivors of childhood brain tumors","volume":"76","author":"Shalitin","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ando.2025.101722_bib0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude lifetime cohort study","volume":"33","author":"Chemaitilly","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2025.101722_bib0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJM199301143280211","article-title":"Radiation and pituitary dysfunction","volume":"328","author":"Shalet","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2025.101722_bib0030","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1210\/jc.2011-0306","article-title":"Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis","volume":"96","author":"Appelman-Dijkstra","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101722_bib0035","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1186\/s12885-019-6431-5","article-title":"Are hypothalamic-pituitary (HP) axis deficiencies after whole brain radiotherapy (WBRT) of relevance for adult cancer patients?\u00a0\u2013\u00a0a systematic review of the literature","volume":"19","author":"Mehta","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ando.2025.101722_bib0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.seminoncol.2019.07.006","article-title":"Normal tissue complication probability (NTCP) models for modern radiation therapy","volume":"46","author":"Palma","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ando.2025.101722_bib0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12885-020-07091-x","article-title":"Sparing the hippocampus and the hypothalamic-pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study","volume":"20","author":"Mehta","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ando.2025.101722_bib0050","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.21873\/anticanres.14595","article-title":"Hypothalamic-pituitary axis dysfunction after whole brain radiotherapy\u00a0\u2013\u00a0a cohort study","volume":"40","author":"Gebauer","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ando.2025.101722_bib0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2014.08.018","article-title":"Pituitary dysfunction in adult patients after cranial irradiation for head and nasopharyngeal tumours","volume":"113","author":"Appelman-Dijkstra","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ando.2025.101722_bib0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/era.12.27","article-title":"Radiotherapy-induced hypopituitarism: a review","volume":"12","author":"Sathyapalan","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ando.2025.101722_bib0065","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/joim.13382","article-title":"Growth hormone deficiency in adults with hypopituitarism\u00a0\u2013\u00a0what are the risks and can they be eliminated by therapy?","volume":"290","author":"Johannsson","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2025.101722_bib0070","doi-asserted-by":"crossref","first-page":"e220365","DOI":"10.1530\/EC-22-0365","article-title":"Growth hormone deficiency in adult survivors of childhood brain tumors treated with radiation","volume":"12","author":"Marie Baunsgaard","year":"2023","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2025.101722_bib0075","series-title":"Endocrine Development [Internet]","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000207607","article-title":"Hypopituitarism following radiotherapy revisited","author":"Darzy","year":"2009"},{"key":"10.1016\/j.ando.2025.101722_bib0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/cen.12969","article-title":"Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours","volume":"84","author":"Kyriakakis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101722_bib0085","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0360-3016(87)90227-6","article-title":"Symptomatic hypothalamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: a retrospective study","volume":"13","author":"Lam","year":"1987","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ando.2025.101722_bib0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2022.01.018","article-title":"The European particle therapy network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation","volume":"168","author":"De Roeck","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ando.2025.101722_bib0095","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1210\/jc.2018-01205","article-title":"GH therapy in childhood cancer survivors: a systematic review and meta-analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101722_bib0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101722_bib0105","doi-asserted-by":"crossref","first-page":"920482","DOI":"10.3389\/fendo.2022.920482","article-title":"Expert opinion on the management of growth hormone deficiency in brain tumor survivors: results from an Italian survey","volume":"13","author":"Di Iorgi","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ando.2025.101722_bib0110","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1210\/en.2018-00601","article-title":"FSH, bone mass, body fat, and biological aging","volume":"159","author":"Zaidi","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2025.101722_bib0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T12:49:57Z","timestamp":1751028597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426625000411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0003426625000411"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2025.101722","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary dysfunction after cranial radiotherapy for brain tumor","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2025.101722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101722"}}